Trial intelligence / Profile preview

AQUAVAN for sedation in flexible bronchoscopy

NCT00306722Phase 3Completed

Sponsor
Eisai Co., Ltd.
Start
Apr 2006
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fospropofol disodium in sedation, sponsored by Eisai Co., Ltd.. Started Apr 2006; status: completed.

02

Drugs

fospropofol disodium
03

Conditions

sedation

Beyond the preview

Go deeper on NCT00306722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00306722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call